Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above
Clinical trial NCT05381350 · COMPLETED
Trial details
- NCT number
- NCT05381350
- Sponsor
- Sinovac Research and Development Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2022-09-26
- Enrollment
- 1750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.